Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,062 total articles
Nvidia sits at the center of a new agentic-AI macroeconomy. Its combination of data-center GPUs, networking, software stacks and enterprise AI services makes it the default infrastructure provider for autonomous, agentic workloads. Valuation is rich but supported by outsized free cash flow, razor-thin leverage and high returns on capital. This trad…
UnitedHealth is getting a clear tailwind from a stronger-than-expected Medicare Advantage rate decision and ongoing Optum margin initiatives. The company already converts large free cash flow and trades at reasonable multiples for a diversified health-services platform. This trade targets a tactical long aiming to capture margin re-rating into upco…
Tesla pulled back into the low $300s after an 11% one-day drop to $341.43. Fundamentals are mixed - revenue has softened and margins compressed, yet Tesla still produces positive free cash flow ($6.22B) and carries little net debt (debt/equity 0.10). Technically the stock is oversold (RSI 33) and trading well below its 50-day ($395) and 200-day ave…
Black Rock Coffee Bar (BRCB) is growing its company-owned, drive-thru-focused footprint across core Western U.S. markets while trading well below its 52-week high. The combination of accelerating store openings, a relatively tight float, and a market cap of roughly $669M supports a long-biased trade. Technicals are constructive for adding on weakne…
CMS's surprise bump to 2027 Medicare Advantage rates materially improves UnitedHealth's revenue outlook. With a reasonable valuation, strong cash flow and technical momentum, I recommend a mid-term long trade: entry $310.80, target $360.00, stop $292.00 (45 trading days). The plan assumes UnitedHealth captures a meaningful share of the $13B industr…
FuboTV (FUBO) has spent the last several months carving a low near $8.31 and has since rallied into the low $12s. With a compact float, heavy short interest and a market cap that looks inexpensive on sales and enterprise-value metrics, there’s a tactical long setup here for traders willing to accept elevated risk. This trade targets a mid-term reco…
Organogenesis announced on 04/06/2026 that its randomized controlled trial of PuraPly AM met the 12‑week wound closure primary endpoint. At a market cap near $295M and an EV of $245M, the shares look attractively priced given the binary clinical overhang is now reduced. This is a tactical long for a mid‑term rebound with a clearly defined entry at …
Rambus is uniquely positioned to benefit from an acute AI memory bottleneck thanks to HBM4 and DDR5 interface products. The stock has pulled back from its 52-week high; with no debt, $1.52B in cash and growing FCF, RMBS is an attractive leveraged swing candidate. This trade lays out a precise entry at $91.10, a $120 target and an $80 stop for a lon…
Blackstone (BX) offers a constructive risk/reward over the next 45 trading days: a $112.63 entry captures a 4.22% yield, attractive free cash flow and an EV/EBITDA of ~12 while pricing in private-credit angst. This trade targets a recovery to $140 with a $103 stop, acknowledging the real possibility of continued outflows or credit stress.
Lamb Weston beat Q3 FY2026 top-line but traded down on margin pressure and one-off ERP headaches. With input costs expected to ease in 2027 and a $250M cost-savings program in flight, we think margins can recover materially. The stock trades at a reasonable EV/EBITDA of 8.3 and yields ~3.7%, offering a cushion while earnings normalize. Upgrade to B…
HEICO (HEI) is seeing near-term pressure from geopolitical uncertainty, but its FAA-approved aftermarket parts franchise, strong cash generation, and a defensive balance sheet make a disciplined long trade attractive. Valuation has come in from the highs and technicals show a shallow oversold setup. Enter on weakness, size modestly, and use a clear…
ADMA Biologics plunged after a short-seller report alleged channel stuffing and triggered multiple law-firm investigations. The market sold first and asked questions later. ADMA's margins, liquidity and positive free cash flow argue the company can absorb reputational damage and restore normalized multiple if allegations don't lead to material rest…
A constructive read of the market reaction: Amgen's favorable TED data reset expectations across the field and knocked down Viridian shares. That weakness, combined with heavy oversold technicals, manageable balance-sheet metrics and a catalyst calendar, makes VRDN an asymmetric long for patient, catalyst-aware traders. Trade plan included with ent…
TAL Education shows tangible operational momentum: fiscal Q3 2025 revenue grew 62.4% and management has been investing in AI-powered learning tools and devices that can drive higher average revenue per student. At a market cap of about $6.8B and a P/E of ~23, the stock looks like a pragmatic swing trade as the market digests growth re-acceleration …
POET Technologies ($POET) is a sub-$1B photonics name trading near $5.80 with partnerships and sample timelines that can re-rate sentiment quickly. This trade idea outlines a mid-term swing entry, stop and target that balance upside from upcoming technical milestones against real dilution and commercialization risk.
Elastic combines open-source roots with cloud monetization, showing 16% YoY revenue growth in Q2 FY2026 and healthy free cash flow. The stock trades near its 52-week low with an enterprise value of roughly $5.07B and an EV/S of ~3.0. We view ESTC as a long with defined risk control: enter at $49.60, stop at $46.00, target $80.00 over a 180-day hori…
Fortinet remains a cash-generating cybersecurity leader, but rising platform competition, aggressive consolidation by peers, and a looming post-quantum migration are compressing the company's margin of error. The trade: short FTNT at $82.60 with a stop at $87.00 and a target of $73.00 over a mid-term horizon (45 trading days).
Lumentum (LITE) is trading like a narrative stock — rich multiples but accelerating fundamentals tied directly to AI data-center bandwidth needs and a direct strategic tie to NVIDIA. We lay out a mid-term swing trade that leans on continued data-center buildout and execution while respecting a stretched valuation and elevated leverage.
<p>Capital City Bank Group (CCBG) trades at about $45 and offers a blend of yield and growth. With EPS at $3.59 and an annualized dividend of $1.08, the bank retains roughly 70% of earnings to fund organic growth and reserves. At a ~12.4x P/E and 1.38x P/B, the stock looks reasonably valued versus the company’s cash generation and conservative leve…
Watches of Switzerland Group (WOSGF) is showing signs of constructive technicals and concentrated short activity that together create a favorable risk/reward for a disciplined long swing. Enter at $6.18 with a $5.60 stop and a $8.00 target. Expect a bumpy ride — trade size accordingly.
WildBrain's recent deal close resets expectations for cash generation and IP monetization. With the market not yet fully repricing the transaction, a disciplined mid-term long (45 trading days) targets a recovery as licensing, content rollouts and channel monetization show early traction. Trade is size-limited and paired with a clear stop to protec…
Figure Technology (FIGR) is widening its marketplace footprint across mortgages, stablecoins and on-chain equity. Recent operating data show strong year-over-year volume growth even as the stock retraced from January highs. This trade idea buys the pullback with a 180-trading-day horizon, defined entry, stop and target and a balanced risk framework…
Super Micro Computer faces a compliance and legal crisis after a U.S. Justice Department indictment alleging illegal exports of servers to China. With a $13.1B market cap, stretched short-covering activity, falling technicals, and confirmed earnings power, the stock is tradable to the downside in the mid-term while uncertainty around contracts, cus…
CMS's 2.48% Medicare Advantage capitation boost (4.98% including risk-score trends) materially improves 2027 revenue outlook for insurers. Elevance combines attractive valuation (P/E ~12), healthy free cash flow ($3.17B), and constructive technicals after the gap-up. This trade targets a return toward $360 with a stop under $288 - a measured swing …
Stoneridge is trading at a deep valuation discount with improving free cash flow, a healthy liquidity profile and product exposure to camera, connectivity and telematics growth. This trade idea lays out a long position with precise entry, stop and target and explains the fundamental case, catalysts, and the risks that could derail it.
